FDA Inspection 1092798 — Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited — FEI 3004011473

The FDA completed an inspection of Intas Pharmaceuticals Limited on May 28, 2019 in Taluka Sanand, Ahmedabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 28, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Taluka Sanand, Ahmedabad (India)